These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 15832623

  • 1. Topiramate in the prophylactic treatment of migraine in children.
    Campistol J, Campos J, Casas C, Herranz JL.
    J Child Neurol; 2005 Mar; 20(3):251-3. PubMed ID: 15832623
    [Abstract] [Full Text] [Related]

  • 2. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.
    Winner P, Pearlman EM, Linder SL, Jordan DM, Fisher AC, Hulihan J, Topiramate Pediatric Migraine Study Investigators.
    Headache; 2005 Mar; 45(10):1304-12. PubMed ID: 16324162
    [Abstract] [Full Text] [Related]

  • 3. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.
    Seeburger JL, Cady RK, Winner P, MacGregor A, Valade D, Ge Y, Zhang Y, Hustad CM, Strickler N, Schaefer E, Connor KM, Ho TW.
    Headache; 2012 Jan; 52(1):57-67. PubMed ID: 22078129
    [Abstract] [Full Text] [Related]

  • 4. Topiramate for migraine prevention in adolescents: a pooled analysis of efficacy and safety.
    Winner P, Gendolla A, Stayer C, Wang S, Yuen E, Battisti WP, Nye JS.
    Headache; 2006 Jan; 46(10):1503-10. PubMed ID: 17115983
    [Abstract] [Full Text] [Related]

  • 5. Topiramate: new indication. Migraine prevention: best avoided.
    Prescrire Int; 2006 Aug; 15(84):132-3. PubMed ID: 16989025
    [Abstract] [Full Text] [Related]

  • 6. Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials.
    Bussone G, Diener HC, Pfeil J, Schwalen S.
    Int J Clin Pract; 2005 Aug; 59(8):961-8. PubMed ID: 16033621
    [Abstract] [Full Text] [Related]

  • 7. The impact of migraine on daily activities: effect of topiramate compared with placebo.
    Silberstein SD, Loder E, Forde G, Papadopoulos G, Fairclough D, Greenberg S.
    Curr Med Res Opin; 2006 Jun; 22(6):1021-9. PubMed ID: 16846536
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, Brandes JL, Bigal M, Saper J, Ascher S, Jordan DM, Greenberg SJ, Hulihan J, Topiramate Chronic Migraine Study Group.
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [Abstract] [Full Text] [Related]

  • 9. Topiramate in migraine prophylaxis: data from a pooled analysis and open-label extension study.
    Bussone G, Usai S, D'Amico D.
    Neurol Sci; 2006 May; 27 Suppl 2():S159-63. PubMed ID: 16688622
    [Abstract] [Full Text] [Related]

  • 10. Topiramate: a case series study in migraine prophylaxis.
    Young WB, Hopkins MM, Shechter AL, Silberstein SD.
    Cephalalgia; 2002 Oct; 22(8):659-63. PubMed ID: 12383061
    [Abstract] [Full Text] [Related]

  • 11. Predictors of a negative response to topiramate therapy in patients with chronic migraine.
    Rothrock JF, Parada VA, Drinkard R, Zweifler RM, Key KF.
    Headache; 2005 Oct; 45(7):932-5. PubMed ID: 15985112
    [Abstract] [Full Text] [Related]

  • 12. A double-blind, dose comparison study of topiramate for prophylaxis of basilar-type migraine in children: a pilot study.
    Lewis D, Paradiso E.
    Headache; 2007 Oct; 47(10):1409-17. PubMed ID: 18052950
    [Abstract] [Full Text] [Related]

  • 13. Topiramate in migraine prevention: evidence-based medicine from clinical trials.
    Silberstein SD.
    Neurol Sci; 2004 Oct; 25 Suppl 3():S244-5. PubMed ID: 15549548
    [Abstract] [Full Text] [Related]

  • 14. Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study.
    Lipton RB, Silberstein S, Dodick D, Cady R, Freitag F, Mathew N, Biondi DM, Ascher S, Olson WH, Hulihan J.
    Cephalalgia; 2011 Jan; 31(1):18-30. PubMed ID: 20974598
    [Abstract] [Full Text] [Related]

  • 15. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
    Rapoport A, Mauskop A, Diener HC, Schwalen S, Pfeil J.
    Headache; 2006 Jan; 46(7):1151-60. PubMed ID: 16866719
    [Abstract] [Full Text] [Related]

  • 16. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ, TOPMAT-MIG-201(TOP-CHROME) Study Group.
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [Abstract] [Full Text] [Related]

  • 17. Topiramate for migraine prevention in a naturalistic setting: results from an open label, flexible dose study.
    Nelles G, Delbrück A, Schulze L, Kademann B, Bornhoevd K, Schäfer S, Schäuble B, TOPMAT-MIG-4009 investigators.
    Headache; 2009 Jul; 49(10):1454-65. PubMed ID: 19804392
    [Abstract] [Full Text] [Related]

  • 18. Topiramate for patients with refractory migraine: an observational, multicenter study in Spain.
    Pascual J, Sánchez del Rio M, Mateos V, Láinez JM, Hernández-Gallego J, Leira R, Jiménez MD.
    Neurologia; 2003 Sep; 18(7):364-7. PubMed ID: 14505244
    [Abstract] [Full Text] [Related]

  • 19. Two center, randomized pilot study of migraine prophylaxis comparing paradigms using pre-emptive frovatriptan or daily topiramate: research and clinical implications.
    Cady RK, Voirin J, Farmer K, Browning R, Beach ME, Tarrasch J.
    Headache; 2012 May; 52(5):749-64. PubMed ID: 22188311
    [Abstract] [Full Text] [Related]

  • 20. Question 3. Topiramate for chronic migraine in children.
    Jayapal S, Maheshwari N.
    Arch Dis Child; 2011 Mar; 96(3):318-21. PubMed ID: 21317129
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.